The Psilocybin vs. Escitalopram Trial – Part 2
A deep dive into the strengths and limitations of the trial.
A deep dive into the strengths and limitations of the trial.
Was psilocybin really effective for treating depression?
A look at some fundamental ideas defining these intriguing compounds.
Properties of psychedelics determine optimal routes of administration.
Blocking the 5-HT2A receptor helps researchers understand psychedelics.
It's likely to follow the compounds that fast track through the clinical psychedelic renaissance.
The relationship between efficacy and potency is a key concept in understanding psychedelic drug pharmacology.
MindMed just started a Phase 1 trial which is studying the effects of LSD + MDMA administered together.
“We have some [compounds] now that are unlike anything you’ve ever seen before.”
A recent study shows DMT reduces the cellular stress caused by a stroke and speeds up recovery time in rats. These findings highlight the expanding therapeutic potential of DMT regarding neurological disorders.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.